Initial Statement of Beneficial Ownership (3)
February 24 2017 - 5:28PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
STARKS DANIEL J
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/16/2017
|
3. Issuer Name
and
Ticker or Trading Symbol
ABBOTT LABORATORIES [ABT]
|
(Last)
(First)
(Middle)
100 ABBOTT PARK ROAD
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
ABBOTT PARK, IL 60064
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common shares without par value
|
6401104
|
D
|
|
Common shares without par value
|
58399
(1)
|
D
|
|
Common shares without par value
|
258
(2)
|
I
|
Alynne Starks 2012 Irrevocable Trust
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Option (right to buy)
(3)
|
1/4/2017
|
1/3/2018
|
Common shares
|
168413
|
$28.50
|
D
|
|
Option (right to buy)
(3)
|
1/4/2017
|
1/3/2018
|
Common shares
|
336131
|
$33.14
|
D
|
|
Explanation of Responses:
|
(
1)
|
St. Jude Medical, Inc. restricted stock unit award that was converted to an Abbott restricted stock unit award in connection with Abbott's acquisition of St. Jude Medical, in a transaction exempt from Section 16 under Rule 16b-3. The restricted stock units are vested and will settle in shares on July 4, 2017.
|
(
2)
|
Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.
|
(
3)
|
St. Jude Medical stock option that was converted to an Abbott stock option in connection with Abbott's acquisition of St. Jude Medical, in a transaction exempt from Section 16 under Rule 16b-3.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
STARKS DANIEL J
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064
|
X
|
|
|
|
Signatures
|
John A. Berry, by power of attorney for Daniel J. Starks
|
|
2/24/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Sep 2023 to Sep 2024